AR051487A1 - Virus del sindrome reproductor y respiratorio porcino mutante - Google Patents

Virus del sindrome reproductor y respiratorio porcino mutante

Info

Publication number
AR051487A1
AR051487A1 ARP050104740A ARP050104740A AR051487A1 AR 051487 A1 AR051487 A1 AR 051487A1 AR P050104740 A ARP050104740 A AR P050104740A AR P050104740 A ARP050104740 A AR P050104740A AR 051487 A1 AR051487 A1 AR 051487A1
Authority
AR
Argentina
Prior art keywords
respiratory syndrome
syndrome virus
porcine reproductive
mutant porcine
mutant
Prior art date
Application number
ARP050104740A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AR051487A1 publication Critical patent/AR051487A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/18—Togaviridae; Flaviviridae
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10041—Use of virus, viral particle or viral elements as a vector
    • C12N2770/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10061—Methods of inactivation or attenuation

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La presente proporciona un virus el PRRS genéticamente modificado y polinucleotidos que lo codifican. También e proporcionan vacunas que comprenden el virus y polinucleotido genéticamente modificados.
ARP050104740A 2004-11-11 2005-11-11 Virus del sindrome reproductor y respiratorio porcino mutante AR051487A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62676704P 2004-11-11 2004-11-11

Publications (1)

Publication Number Publication Date
AR051487A1 true AR051487A1 (es) 2007-01-17

Family

ID=36061457

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050104740A AR051487A1 (es) 2004-11-11 2005-11-11 Virus del sindrome reproductor y respiratorio porcino mutante

Country Status (16)

Country Link
US (1) US7879337B2 (es)
EP (1) EP1812573A1 (es)
JP (1) JP2008519594A (es)
KR (1) KR20070064666A (es)
CN (1) CN101056982A (es)
AR (1) AR051487A1 (es)
AU (1) AU2005303510B2 (es)
BR (1) BRPI0517745A (es)
CA (1) CA2586153C (es)
IL (1) IL182976A0 (es)
MX (1) MX2007005708A (es)
NO (1) NO20072578L (es)
RU (1) RU2007117510A (es)
TW (1) TW200636067A (es)
WO (1) WO2006051396A1 (es)
ZA (1) ZA200703762B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8404253B2 (en) * 2006-12-28 2013-03-26 Newport Laboratories, Inc. Modified live (JMSO strain) Haemophilus parasuis vaccine
PL2675475T3 (pl) * 2011-02-17 2015-12-31 Boehringer Ingelheim Vetmedica Gmbh Nowy europejski szczep prrs
ES2932952T3 (es) * 2012-04-24 2023-01-30 Ohio State Innovation Foundation Composiciones y métodos para tratar y prevenir el síndrome reproductivo y respiratorio porcino

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7132106B2 (en) * 1998-12-22 2006-11-07 Pfizer Inc. Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
NZ501264A (en) * 1998-12-22 2001-09-28 Pfizer Prod Inc Polynucleotide DNA sequence encoding an infectious RNA molecule encoding a North American PRRS
MXPA01010681A (es) 1999-04-22 2003-08-20 Us Agriculture Vacuna de sindrome respiratorio y reproductiva porcina a base de ja-142 aislado.
US20020012670A1 (en) * 2000-01-26 2002-01-31 Knut Elbers Recombinant attenuation of porcine reproductive and respiratory syndrome (PRRSV)
EP1397498A1 (en) 2001-05-21 2004-03-17 ID-Lelystad, Instituut voor Dierhouderij en Diergezondheid B.V. Delections in arterivirus replicons
US6841364B2 (en) 2002-01-22 2005-01-11 Protatek International, Inc. Infectious cDNA clones of porcine reproductive and respiratory syndrome virus and expression vectors thereof
EP1438969A1 (en) * 2003-01-14 2004-07-21 Universiteit Utrecht Arterivirus marker vaccine

Also Published As

Publication number Publication date
BRPI0517745A (pt) 2008-10-21
KR20070064666A (ko) 2007-06-21
WO2006051396A1 (en) 2006-05-18
JP2008519594A (ja) 2008-06-12
EP1812573A1 (en) 2007-08-01
AU2005303510A1 (en) 2006-05-18
CN101056982A (zh) 2007-10-17
US7879337B2 (en) 2011-02-01
ZA200703762B (en) 2008-09-25
NO20072578L (no) 2007-08-02
AU2005303510B2 (en) 2011-02-03
IL182976A0 (en) 2007-08-19
CA2586153A1 (en) 2006-05-18
MX2007005708A (es) 2007-07-09
CA2586153C (en) 2012-04-03
US20090004221A1 (en) 2009-01-01
RU2007117510A (ru) 2008-11-20
TW200636067A (en) 2006-10-16

Similar Documents

Publication Publication Date Title
AR052392A1 (es) Mutantes de la proteina n del virus del sindrome reproductor y respiratorio de los porcinos
NL300936I2 (nl) Semaglutide
PL1951882T3 (pl) Kwasy nukleinowe kodujące szczepionkę przeciwko wirusowi wywołującemu zespół zaburzeń reprodukcyjnych i oddechowych u świń
FR17C1020I2 (fr) Fsh recombinante comprenant la sialylation alpha 2,3 et alpha 2,6
EP1794329A4 (en) ISOLATES OF PORCINE RESPIRATORY DYSGENESIS SYNDROME (SDRP), AND METHODS OF USE
TW200605416A (en) Light emitting device processes
ATE465176T1 (de) Il-7-varianten mit reduzierter immunogenität
NL1029787C2 (nl) Verlichtingseenheid voorzien van led en beeldprojectie-inrichting voorzien van verlichtingseenheid.
EP1802728A4 (en) PHOSPHOR AND LIGHT EMITTING DEVICE USING THE SAME
WO2006014363A3 (en) Curing light
NL1025576A1 (nl) CT detector met geïntegreerde luchtopening.
TW200638764A (en) Water-cooled projector
EP1976838A4 (en) OXADIAZOL DERIVATIVE AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE AND ELECTRONIC DEVICE USING THE OXADIAZONE DERIVATIVE
AR051487A1 (es) Virus del sindrome reproductor y respiratorio porcino mutante
ATE542247T1 (de) Weisslicht- oder ultraviolett-leds mit einem getter-system
TW200724644A (en) A metallic emitter made emitter from a organic luminous element and the luminous element
ATE396653T1 (de) Nadelvorrichtung mit pivotierbarem nadelschutz
DK2063738T3 (da) Sædeindretning, især taburet
CL2007002797A1 (es) Composicion terapeutica que comprende un anticuerpo contra el receptor del egf, interferon y excipientes adecuados para su administracion por via intravenosa.
GB201112172D0 (en) Lamp device
GT200300027S (es) Botella.
UA89660C2 (ru) Мутанты n-протеина вируса репродуктивного и респираторного синдрома свиней
Mori et al. Luminous environment evaluation of the task and ambient lighting system using LED's
DE602006001721D1 (de) Elektronenquelle geschützt durch eine Schutzschicht und einen Elektronenemitter mit der Elektronenquelle
GB2453084A (en) Novel polypeptides for an anti-viral treatment

Legal Events

Date Code Title Description
FB Suspension of granting procedure